These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1229 related articles for article (PubMed ID: 31897151)

  • 21. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
    Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
    Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
    Yang MR; Zhang Y; Wu XX; Chen W
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profile analysis of colorectal cancer to investigate potential mechanisms using bioinformatics.
    Kou Y; Zhang S; Chen X; Hu S
    Onco Targets Ther; 2015; 8():745-52. PubMed ID: 25914544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
    Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms investigation for liver metastasis of colorectal cancer by combined bioinformatic gene expression profile analysis.
    Wu QQ; Wang XY; Wu WX; Chen YX; Wang J; Zhang X; Qian Y; Du SS; Sun J; Zeng ZC
    Cancer Treat Res Commun; 2023; 35():100694. PubMed ID: 36868002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of four novel hub genes as monitoring biomarkers for colorectal cancer.
    Luo D; Yang J; Liu J; Yong X; Wang Z
    Hereditas; 2022 Jan; 159(1):11. PubMed ID: 35093172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.
    Chang H; Jin L; Xie P; Zhang B; Yu M; Li H; Liu S; Yan J; Zhou B; Li X; Xu Y; Xiao Y; Ye Q; Guo L
    J Gastrointest Oncol; 2022 Oct; 13(5):2351-2365. PubMed ID: 36388659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
    Huang Z; Yang Q; Huang Z
    Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a three-gene-based prognostic model in multiple myeloma using bioinformatics analysis.
    Pan Y; Meng Y; Zhai Z; Xiong S
    PeerJ; 2021; 9():e11320. PubMed ID: 34249481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of hub genes in colon cancer via bioinformatics analysis.
    Liu J; Sun GL; Pan SL; Qin MB; Ouyang R; Huang JA
    J Int Med Res; 2020 Sep; 48(9):300060520953234. PubMed ID: 32961078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
    Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
    J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.
    Li Z; Sang M; Tian Z; Liu Z; Lv J; Zhang F; Shan B
    Oncol Lett; 2019 Nov; 18(5):4429-4440. PubMed ID: 31611952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.